tiprankstipranks
Trending News
More News >
Cerus Corporation (CERS)
:CERS
US Market
Advertisement

Cerus (CERS) Earnings Dates, Call Summary & Reports

Compare
738 Followers

Earnings Data

Report Date
Feb 19, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.01
Last Year’s EPS
-0.01
Same Quarter Last Year
Based on 4 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
Cerus Corporation's earnings call for Q3 2025 highlighted significant revenue growth and positive financial performance, driven by strong demand for INTERCEPT products and successful international expansion efforts. However, the company faces challenges with gross margin pressures and regulatory delays in Europe. Despite these hurdles, the overall outlook remains optimistic with raised revenue guidance and continued focus on operational execution.
Company Guidance
In the Cerus Corporation Third Quarter 2025 Earnings Conference Call, the company provided key guidance and metrics for its financial and operational expectations. The company raised its full-year 2025 product revenue guidance to a range of $202 million to $204 million, an increase from the previous range of $200 million to $203 million, driven by robust demand for its INTERCEPT portfolio. Cerus also expects full-year 2025 IFC sales to be between $16 million and $17 million, slightly adjusted from the earlier guidance of $16 million to $18 million, due to a strategic shift towards sales through kits. The company reported a record quarterly product revenue of $52.7 million, marking a 15% year-over-year increase, with gross margins anticipated to remain in the 50% range despite headwinds such as tariffs and inflation. Cerus achieved its sixth consecutive quarter of positive non-GAAP adjusted EBITDA, reaching $5 million for Q3, and is on track to meet its goal of full-year positive adjusted EBITDA. The company's U.S. market penetration for INTERCEPT is estimated in the mid-60% range, with expectations to grow well into the 70% and beyond. Additionally, international growth is supported by Cerus' role in the German INITIATE study and the INT200 illuminator launch across Europe.
Record Product Revenue
Product revenue for Q3 2025 reached $52.7 million, a 15% year-over-year increase. The revenue increase was driven by strong platelet demand and growing IFC adoption.
Increased Revenue Guidance
Cerus raised its full-year 2025 product revenue guidance to $202 million to $204 million, reflecting confidence in continued momentum across their franchises.
Strong IFC Growth
IFC product revenue for Q3 was $3.9 million, a 70% increase from the previous year, with demand more than doubling as hospitals recognize its clinical and operational benefits.
Positive Non-GAAP Adjusted EBITDA
Cerus reported its sixth consecutive quarter of positive non-GAAP adjusted EBITDA, totaling $5 million for Q3 2025.
Expansion in Germany
Cerus was selected by the German Red Cross Blood Service to support the INITIATE study, marking an important step for potential growth in Germany.

Cerus (CERS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CERS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 19, 2026
2025 (Q4)
-0.01 / -
-0.01
Nov 06, 2025
2025 (Q3)
-0.03 / 0.00
-0.02
Aug 05, 2025
2025 (Q2)
-0.03 / -0.03
-0.030.00% (0.00)
May 01, 2025
2025 (Q1)
-0.04 / -0.04
-0.0520.00% (+0.01)
Feb 20, 2025
2024 (Q4)
-0.01 / -0.01
-0.010.00% (0.00)
Oct 30, 2024
2024 (Q3)
-0.03 / -0.02
-0.0450.00% (+0.02)
Aug 01, 2024
2024 (Q2)
-0.04 / -0.03
-0.0757.14% (+0.04)
May 02, 2024
2024 (Q1)
-0.05 / -0.05
-0.0944.44% (+0.04)
Mar 05, 2024
2023 (Q4)
-0.03 / -0.01
-0.0887.50% (+0.07)
Nov 02, 2023
2023 (Q3)
-0.05 / -0.04
-0.0520.00% (+0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CERS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2025
$1.41
Aug 05, 2025
$1.28$1.29+0.78%
May 01, 2025
$1.30$1.35+3.85%
Feb 20, 2025
$1.74$1.65-5.17%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Cerus Corporation (CERS) report earnings?
Cerus Corporation (CERS) is schdueled to report earning on Feb 19, 2026, After Close (Confirmed).
    What is Cerus Corporation (CERS) earnings time?
    Cerus Corporation (CERS) earnings time is at Feb 19, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CERS EPS forecast?
          CERS EPS forecast for the fiscal quarter 2025 (Q4) is -0.01.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis